Global Clinical Trials, LLC (“GCT”) is a well-established CRO providing clinical development services for drugs and medical devices since 2001, headquartered in Princeton, NJ, US, and operationally focused on Central-Eastern Europe and Russia.
Currently employing over 60 people and led by a management team with 50+ years of combined clinical trials experience, GCT has 7 local offices across 9 countries and continues to expand its geographical coverage each year.
An office in St. Petersburg, Russia, is established
GCT initiates a first local clinical trial
US headquarters opened in Princeton, NJ
Clinical operations office in Bulgaria established
GCT becomes an exclusive partner of “The White Nights” international ophthalmology congress in CIS
New offices in Ukraine and Romania are set up
FDA inspectors visit GCT facilities in Russia while examining investigative sites participating in a GI phase III project; no major findings reported
Expansion to Hungary and the Czech Republic
GCT pioneers in a Russian government-sponsored pharmaceutical clinical development program
GCT Ukrainian office successfully passes a regulatory inspection by local authority (Ministry of Health)
Expansion to the Slovak Republic
New office in Budapest opened
GCT Russian office successfully passes a regulatory inspection by local authority (Federal Healthcare Surveillance Service)
Expansion to Poland — new office in Warsaw
Expansion to India — new office in Mumbai
Expansion to Moldova
Jeffrey Apter, MD, President
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
Eugene Selivra, MD, CEO
Having received his medical degree from Pavlov Medical School in St. Petersburg, Russia in 1985 and followed by heading a department at the prestigious Bekhterev Psychiatric Institute, making over 10 publications in CNS clinical research, Dr. Selivra has 25+ years of experience conducting and managing multi-therapeutic trials in US, Europe and Russia.
As a recognized expert in CNS field he retains a solid authority within clinical research community in the region.
Mission & Vision
Our priority is to provide our clients with the highest quality of clinical data in the shortest period of time while making the most of the opportunities offered by the regions we cover: loyal and interested patient population, motivated investigators, local legislation aligned with international standards, and competitive pricing.
We wish to unlock the region’s potential both for local and international Sponsors and thus offer our unparalleled expertise in cooperating with the national regulatory authorities, tackling logistical aspects of the trials, and ensuring strong project management throughout study execution.